Search Results 971-980 of 18364 for Hepatitis b

1. Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein - Mayo Clinic

   hepatitis B or C, primary biliary cirrhosis, primary sclerosing cholangitis, Wilson disease, alcoholic hepatitis, hemochromatosis, liver cancer, history ...

2. Cirrhosis Clinical Trials - Mayo Clinic Research

   ... hepatitis C virus (HCV) study or commercially at selected sites. ... B cirrhosis. A Study to Evaluate Liver Stiffness ... hepatitis C virus study or commercially at ...

3. A Study to Evaluate the Safety and Effectiveness of BIIB054 in Subjects with Parkinson’s Disease - Mayo Clinic

   Current hepatitis B infection (defined as positive for hepatitis B surface antigen [HBsAg] and/or total hepatitis B core antibody [anti-HBc]). Subjects with ...

4. A Study to Evaluate Parsaclisib (INCB050465), Rituximab, Cyclophosphamide, Doxorubicin, Vincristine And Prednisone (Par-CHOP) Immunochemotherapy for Patients with Newly Diagnosed High Risk Diffuse Large B-Cell Lymphoma - Mayo Clinic

   ... B-Cell Lymphoma. Print details. Share; Facebook · Twitter. Overview ... NOTE: If evidence of chronic hepatitis B virus (HBV) infection, HBV viral ...

5. Publications - Michael B. Phillips, M.D. - Mayo Clinic

   McCormick BJ, Zieman D, West-Santos C, Phillips MB. Immune checkpoint inhibitor lichenoid eruption due to pembrolizumab. BMJ Case Rep.

6. T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer - Mayo Clinic

   - Patients with known active and/or untreated hepatitis B or hepatitis C or chronic liver disease are ineligible. Patients with a diagnosis of hepatitis B ...

7. A Study to Evaluate the Safety and Effectiveness of AB928-Based Treatment Combinations to Treat Patients with Metastatic Colorectal Cancer - Mayo Clinic

   - Negative HIV, Hep B and Hep C antibody testing - Agreement to remain ... limited to, myasthenia gravis, myositis, autoimmune hepatitis, systemic lupus

8. Exploratory Ph 2A, Double-Blind, Placebo-Controlled Dose Escalation Study of Safety, Tolerability, PD, & PK of HU6 for Subjects With Obese HFpEF - Mayo Clinic

   Serologic evidence of Hepatitis B based on hepatitis B surface antigen (HBsAG); e. Serologic evidence of Hepatitis C antibody (HCV Ab) and HCV RNA; f.

9. Hemophilia - Symptoms and causes - Mayo Clinic

   If the clotting factors used to treat hemophilia come from human blood, there's an increased risk of viral infections such as hepatitis C. Because of donor ...

10. Inotuzumab Ozogamicin in Treating Younger Patients With Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia - Mayo Clinic

    ... B Acute Lymphoblastic Leukemia ... Active viral or protozoal infection requiring IV treatment. Patients with known human immunodeficiency virus (HIV), hepatitis B ...